Accelerating Cancer Cures

aka Padres Pedal the Cause   |   San Diego, CA   |
GuideStar Charity Check


EIN: 46-0552414


To mobilize San Diego to accelerate cancer cures in our lifetime.

Ruling year info



Anne Marbarger

Main address

9191 Towne Centre Dr. Suite 310

San Diego, CA 92121 USA

Show more contact info



Subject area info


Health care quality



Population served info

Children and youth



Chronically ill people

Terminally ill people

NTEE code info

Fund Raising and/or Fund Distribution (T12)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Tax forms


Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Curebound is a San Diego-based 501c3 philanthropic organization that raises and invests strategic funding in translational cancer research projects aimed at accelerating new discoveries to clinical application. Our mission - mobilize San Diego to accelerate cures for cancer in our lifetime. Our vision - a world without cancer.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Discovery Grants

One-time seed grants of up to $250,000 for high-risk/ high-reward, translational research. Ideas are innovative and in the early phases where smaller grants can make a big impact in advancing research. Discovery Grants prioritize research that advances therapeutic development and/or has a high likelihood of leveraging extramural funding. Inter-institutional collaboration is required.

Population(s) Served

Larger gifts of $500,000 that aim to fund projects that are closer to clinical stages. Inaugural Targeted Grants require a clinical researcher to be part of the collaborative team in order to ensure the project is geared toward translational application. Priority is given to applications that have a high likelihood of significantly advancing detection, prevention, therapeutic development, access to patient care and/or clinical trials. Targeted Grants fund continuity of ideas from the investigators’ past research, including research that builds upon previously funded Discovery Grants. Interdisciplinary collaboration is required and inter-institutional collaboration, while not required, is preferred.

Population(s) Served

Curebound’s highest award for bold innovation in cancer research. Cure Prizes are awarded to teams who present collaborative and/or interdisciplinary solutions that show near-term promise of clinical breakthrough and represent “game changers” in the prevention, diagnosis, access or treatment of cancer patients. Grant funding of $1,000,000+ is awarded and administered over a period of 2-3 years. The first Cure Prize challenge is to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in 3-5 years.

Population(s) Served
Chronically ill people
Terminally ill people
Children and youth
Chronically ill people
Terminally ill people
Children and youth
Chronically ill people
Terminally ill people
Children and youth
Chronically ill people
Terminally ill people
Children and youth

Where we work


Small Nonprofit of the Year 2022

San Diego Business Journal

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

Curebound unites San Diego’s top research institutions in a collaborative effort to accelerate cancer research into cures. Founded upon a deeply held belief that cures are possible, we believe – and we are seeing – that the next decade will be critical to the development of sophisticated, individualized cancer treatment and the largest opportunity ever seen to advance the way we treat, and ultimately cure cancer. All of this is possible in San Diego.

San Diego is recognized as one of the largest and fastest growing life-science communities in the country and is uniquely positioned as a global center for cancer research, innovation and care. The city is home to three NCI-designated cancer centers, internationally recognized biotech research institutions, top clinical care hospitals and nearly 1,000 life-science companies that are taking cancer discoveries to clinical and commercial stages. Headquartered amongst this powerful scientific hub, Curebound is the catalyst to bring these resources together to drive this work faster and further- to expedite discovery and improve the lives of patients today.

Collaboration is at the center of Curebound’s unique grantmaking platform. All Curebound grants demand collaboration among specialized teams from our research partner institutions, enabling the brightest minds from different scientific disciplines to work together to produce better options and outcomes for patients. Curebound research partners include:

- Moores Cancer Center at UC San Diego Health
- Salk Institute
- Sanford-Burnham Prebys
- Rady Children’s Hospital
- La Jolla Institute for Immunology
- Scripps Research

Curebound funds promising, innovative oncology research for all types of cancer, adult and pediatric, in alignment with five scientific investment pillars:

- Prevention and diagnostic tools
- Novel approaches and new therapeutic platforms
- Immunotherapies and personalized vaccines
- Cancer equities
- Pediatric cancers

In 2021 two highly respected local cancer organizations, the Immunotherapy Foundation and Padres Pedal the Cause, united to form Curebound with an initial goal to raise and invest $100+ million into collaborative cancer research in San Diego. Over the last decade, these two organizations have collectively awarded over $23 million in funding for 90+ research grants that explore 20+ types of adult and pediatric cancers, including 6 pioneering clinical trials and major funding to initiate an Advanced Cell Therapy Lab and the San Diego Center for Precision Immunotherapy.

How we listen

SOURCE: Self-reported by organization

Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.

done We shared information about our current feedback practices.
  • How is your organization using feedback from the people you serve?

    To identify and remedy poor client service experiences, To identify bright spots and enhance positive service experiences, To strengthen relationships with the people we serve, To understand people's needs and how we can help them achieve their goals

  • Which of the following feedback practices does your organization routinely carry out?

    We aim to collect feedback from as many people we serve as possible, We take steps to ensure people feel comfortable being honest with us, We look for patterns in feedback based on people’s interactions with us (e.g., site, frequency of service, etc.), We engage the people who provide feedback in looking for ways we can improve in response, We act on the feedback we receive

  • What challenges does the organization face when collecting feedback?

    It is difficult to get the people we serve to respond to requests for feedback


Fiscal year: Jan 01 - Dec 31
Financial documents
2021 Curebound
done  Yes, financials were audited by an independent accountant. info

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2022 info

SOURCE: IRS Form 990


Average of 1.54 over 10 years

Months of cash in 2022 info

SOURCE: IRS Form 990


Average of 7.6 over 10 years

Fringe rate in 2022 info

SOURCE: IRS Form 990


Average of 10% over 10 years

Funding sources info

Source: IRS Form 990

Assets & liabilities info

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990


Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data


Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data


Financial trends analysis Glossary & formula definitions

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

This snapshot of Curebound’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Business model indicators

Profitability info 2017 2018 2019 2020 2022
Unrestricted surplus (deficit) before depreciation -$19,559 $79,272 -$50,121 $510,179 $6,847,535
As % of expenses -0.5% 1.8% -1.1% 59.8% 111.2%
Unrestricted surplus (deficit) after depreciation -$34,595 $60,700 -$68,590 $490,847 $6,775,799
As % of expenses -0.9% 1.4% -1.5% 56.3% 108.8%
Revenue composition info
Total revenue (unrestricted & restricted) $3,679,754 $4,421,873 $4,556,994 $1,362,913 $19,804,413
Total revenue, % change over prior year 15.4% 20.2% 3.1% -70.1% 0.0%
Program services revenue 5.2% 5.4% 6.2% 0.0% 14.8%
Membership dues 0.0% 0.0% 0.0% 0.0% 0.0%
Investment income 0.0% 0.0% 0.0% 0.0% 0.0%
Government grants 0.0% 0.0% 0.0% 0.0% 0.0%
All other grants and contributions 94.8% 94.3% 93.5% 100.0% 85.2%
Other revenue 0.0% 0.4% 0.3% 0.0% 0.0%
Expense composition info
Total expenses before depreciation $3,689,763 $4,352,151 $4,607,115 $852,734 $6,157,333
Total expenses, % change over prior year 13.0% 18.0% 5.9% -81.5% 0.0%
Personnel 14.2% 12.7% 12.1% 55.8% 18.7%
Professional fees 0.7% 1.9% 1.7% 10.1% 17.4%
Occupancy 1.2% 1.3% 1.4% 7.4% 0.1%
Interest 0.0% 0.0% 0.0% 0.0% 0.0%
Pass-through 65.1% 67.6% 67.9% 0.0% 48.7%
All other expenses 18.7% 16.5% 16.9% 26.7% 15.1%
Full cost components (estimated) info 2017 2018 2019 2020 2022
Total expenses (after depreciation) $3,704,799 $4,370,723 $4,625,584 $872,066 $6,229,069
One month of savings $307,480 $362,679 $383,926 $71,061 $513,111
Debt principal payment $0 $0 $0 $0 $0
Fixed asset additions $0 $0 $0 $0 $0
Total full costs (estimated) $4,012,279 $4,733,402 $5,009,510 $943,127 $6,742,180

Capital structure indicators

Liquidity info 2017 2018 2019 2020 2022
Months of cash 8.3 8.7 8.5 9.6 20.1
Months of cash and investments 8.3 8.7 8.5 9.6 20.1
Months of estimated liquid unrestricted net assets 0.9 0.9 0.7 10.6 13.8
Balance sheet composition info 2017 2018 2019 2020 2022
Cash $2,566,468 $3,151,021 $3,254,098 $682,767 $10,319,720
Investments $0 $0 $0 $0 $0
Receivables $181,160 $144,219 $142,230 $135,490 $13,044,813
Gross land, buildings, equipment (LBE) $0 $0 $0 $0 $0
Accumulated depreciation (as a % of LBE) 0.0% 0.0% 0.0% 0.0% 0.0%
Liabilities (as a % of assets) 89.9% 90.1% 92.4% 14.0% 14.0%
Unrestricted net assets $273,532 $334,232 $265,642 $756,489 $7,082,323
Temporarily restricted net assets $9,550 $0 N/A N/A N/A
Permanently restricted net assets $0 $0 N/A N/A N/A
Total restricted net assets $9,550 $0 $0 $0 $13,201,698
Total net assets $283,082 $334,232 $265,642 $756,489 $20,284,021

Key data checks

Key data checks info 2017 2018 2019 2020 2022
Material data errors No No No No No


The people, governance practices, and partners that make the organization tick.

Form 1023/1024 is not available for this organization


Anne Marbarger

Anne Marchand is the CEO of Curebound. With her eyes set on significantly growing the organization, Anne is responsible for building a community of sponsors, riders, fundraisers and passionate cancer warriors in support of the organization's mission to fund the best collaborative cancer research in San Diego. Anne began working with Pedal the Cause in 2015 as Director of Programs and was promoted to lead the organization the following year.

Number of employees

Source: IRS Form 990


Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

There are no highest paid employees recorded for this organization.


Board of directors
as of 09/01/2023
SOURCE: Self-reported by organization
Board of directors data
Download the most recent year of board of directors data for this organization
Board chair

William Koman

Fernanda Whitworth

Larry Bloch

Mark Cafferty

San Diego Regional Economic Development Co

Aaron Davis

Boxer Capital

Rich Heyman

ARCH Venture Partners

John Hood

Endeavor Biomedicines

Catriona Jamieson

UC San Diego

Donald Kearns

Christian Tresse

Bernstein Private Wealth Management

Cheryl Anderson

Magda Marquet

Rob Singh


Daniel Ryan

Alexandria Real Estate Equities

Donald Ankeny


Organizational demographics

SOURCE: Self-reported; last updated 8/28/2023

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.


The organization's leader identifies as:

Race & ethnicity
Gender identity
Disability status
Person without a disability

Race & ethnicity

No data

Gender identity


Sexual orientation

No data


No data

Equity strategies

Last updated: 09/01/2023

GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more

  • We analyze disaggregated data and root causes of race disparities that impact the organization's programs, portfolios, and the populations served.
  • We disaggregate data to adjust programming goals to keep pace with changing needs of the communities we support.
Policies and processes
  • We use a vetting process to identify vendors and partners that share our commitment to race equity.
  • We help senior leadership understand how to be inclusive leaders with learning approaches that emphasize reflection, iteration, and adaptability.
  • We engage everyone, from the board to staff levels of the organization, in race equity work and ensure that individuals understand their roles in creating culture such that one’s race identity has no influence on how they fare within the organization.